It has been shown that a non-laboratory-based risk assessment that can be undertaken in a primary care consultation (age, sex, smoking, diabetes, blood pressure and family history of cardiovascular disease) was at least as good as a biochemistry panel that included IGFBP-1 or further sophisticated measurements, e.g., endothelial dysfunction [132]. The gene discussed is IGFBP1; the disease is cardiovascular disorder.